Member Info for sphinx100

If anyone can get this download it might have some useful info. https://www.tmogroup.asia/downloads/china-health-supplements-market-data-pack-april-2023-en-free/

An open offer at say .6p and 100m shares would solve the funding problem as far as I’m concerned , wouldn’t be too much dilution and give the company £600 k to take us forward , a bit simplistic but then I’m not running a small company with massive potential.

N

Just stating a fact, no need for abuse. !

It doesn’t matter how many shares you own dealing on insider information is against the rules !

And it’s DSM who will have to deal with our renewed interest global player ( uni/CC) “ In June 2022 Provexis and DSM announced a new long-term partnership relating to the gut microbiome patent application which the Company filed in June 2022. New products arising from this collaboration are expected to be dealt with by DSM's Premix and Market-Ready Solutions businesses.“

Looks like someone put a sell order in for 6778255 so the mms dropped the sp to get it away, and it worked , ! The 2688106 is almost certainly a isa transfer

Great buying opportunity this morning which I and others have taken advantage of ,also kept some in reserve just in case a lower buying price or open offer happens .

We’ll need to keep an eye out for the 30m sells then over the next few days , there’ll be an opportunity to pick up some cheap shares me thinks .

Anyone got any thoughts on why ff+ order numbers are down for the last few months ?

Https://www.thisismoney.co.uk/money/mortgageshome/article-12103043/Property-asking-price-bounce-shows-signs-recovery-says-Rightmove.html?ico=mol_desktop_money-newtab&molReferrerUrl=https%3A%2F%2Fwww.dailymail.co.uk%2Fmoney%2Findex.html&_gl=1*q3cfsc*_ga*NDQ2MDM0MTYuMTY4MTExMDIzMQ..*_ga_XE0XLFFF16*MTY4NDgxODY5OC4yNC4wLjE2ODQ4MTg3MDIuMC4wLjA.&_ga=2.205692179.1297138794.1684654147-44603416.1681110231

It does sound like the products are finished and ready for market,just waiting for those approvals .

Could be this ‘ You can set aside an inventory amount to be used for a selected channel or customer. This inventory amount is called product inventory reserve. The reserve has a specified quantity and a time period during which it is active. While active, the reserved amount is deducted from the sellable inventory and incoming orders deduct from that reserved amount with priority. Once the time period expires or the reserved amount is used up, the inventory reserved becomes inactive and the quantity is released back to the overall quantity. Note that similar functionality is available for the Channel Warehouse feature. Product reserves can be created manually and in bulk.‘

Are the “product reserve “an amount of the final format made to test the market , i might be wrong on that , perhaps someone knows more about it to explain .

Not sure what has changed , ....https://patentscope.wipo.int/search/en/detail.jsf?docId=JP390583921&_cid=P21-LH82JE-21704-1

Another option was that trade was from last week when I picked a few up at .6455 and the ask was under .7p so an buy at that size would have been above the ask .!

To me it looks like a mid price trade minus a discount ! So some speculation that it is a buy , with no confirmation yet ! I am optimistically hopeful .

As that comes too 196k could be a placing !

28m just gone through not sure if it’s a buy or sell ,could be transfer.

Are inheritance tax free , if this stretches on many more years at least my kids will be ok . “Investing in small companies can help
If you buy shares listed on the Alternative Investment Market (AIM), they are free from inheritance tax once you have held them for two years.

Invest successfully and the savings could be huge, as any assets above the inheritance allowances are walloped with a 40 per cent tax bill. However, the inheritance tax benefit is a reward for taking considerable risk by investing in small, often untested UK-listed companies.

Therefore this approach is only right for experienced investors who understand the risks and can afford to lose money should it not work out.

AIM is the London Stock Exchange's market for small and medium-sized companies in their growth stage. Inevitably these companies are much riskier to invest in than those that have been established for a long time.

They are more likely to go bust, or see their values plummet. For example, the share price of AIM-listed outsourcing group iEnergizer collapsed last week, when it announced it was delisting from the exchange. That will have left some investors nursing losses and unable to trade their shares as easily.

But equally, because they are still in their infancy, AIM companies are more likely to see rapid growth.